Effects of Matrine on proliferation and differentiation in K-562 cells

被引:155
作者
Zhang, LP [1 ]
Jiang, JK
Tam, JWO
Zhang, Y
Liu, XS
Xu, XR
Liu, BZ
He, YJ
机构
[1] Chongqing Univ Med Sci, Chongqing 400046, Peoples R China
[2] Univ Hong Kong, Fac Med, Dept Biochem, Hong Kong, Hong Kong, Peoples R China
基金
匈牙利科学研究基金会;
关键词
Matrine; K-562 cell line; proliferation; differentiation; cell cycle; telomerase activity; oncogene expression;
D O I
10.1016/S0145-2126(00)00145-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We investigated the effects of Matrine on proliferation by trypan blue exclusion and differentiation by benzidine staining positive cells in K-562 cells, assayed the telomerase activity using PCR-ELISA assay, analyzed cell cycle by fluorescence-activated cell sorter analysis of the DNA content, and also determined the gene expression level of c-myc, N-ras and p53 by northern blot and dot blot analysis. The results showed that with the addition of 0.1 mg/ml Matrine, cell growth was inhibited significantly by 4 days, benizidine-positive cells rose from 1% to 2% in control cells to 15% in treated cells on day 5; treatment of K-562 cells with 0.1 mg/ml Matrine for 5 days resulted in a marked inhibition in telomerase activity, in a manner that correlated with the extent of differentiation, after exposure to Matrine for 72 h, 64.6% cells were arrested in the Gl-phase of the cell cycle, the fraction of cells in S-phase had decreased from 56.9% in control cells to 24.4% in differentiated cells, and the levels of N-ras and p53 mRNA were remarkably increased for 24 and 48 h, respectively, c-myc mRNA expression level declined for 24 h and was inhibited significantly for 48 h. Our study confirmed that Matrine plays a significant effect on the inhibition of proliferation cells and inducing differentiation in K-562 cells. (C) 2001 Published by Elsevier Science Ltd.
引用
收藏
页码:793 / 800
页数:8
相关论文
共 16 条
[1]  
Bestilny LJ, 1996, CANCER RES, V56, P3796
[2]  
CHANG FJ, 1993, AM J GASTROENTEROL, V88, P174
[3]   TELOMERASE ACTIVITY IN NORMAL LEUKOCYTES AND IN HEMATOLOGIC MALIGNANCIES [J].
COUNTER, CM ;
GUPTA, J ;
HARLEY, CB ;
LEBER, B ;
BACCHETTI, S .
BLOOD, 1995, 85 (09) :2315-2320
[4]  
FILMUS J, 1985, CANCER RES, V45, P822
[5]  
HAN R, 1996, RES DEV ANTICANCER D, P48
[6]   USE OF ALL-TRANS RETINOIC ACID IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA [J].
HUANG, ME ;
YE, YC ;
CHEN, SR ;
CHAI, JR ;
LU, JX ;
ZHOA, L ;
GU, LJ ;
WANG, ZY .
BLOOD, 1988, 72 (02) :567-572
[7]  
JENKINSON D, 1997, BIOCHEM SOC T, V25, P252
[8]  
KEYOMARSI K, 1991, CANCER RES, V51, P3602
[9]   CANCER - P53, GUARDIAN OF THE GENOME [J].
LANE, DP .
NATURE, 1992, 358 (6381) :15-16
[10]   THE FUNCTIONS OF MYC PROTEINS [J].
MEICHLE, A ;
PHILIPP, A ;
EILERS, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1114 (2-3) :129-146